Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years or Not Candidates for Intensive Chemotherapy

NCT02606825 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT02606825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02606825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years or Not Candidates for Intensive Chemotherapy
Lead sponsor
PETHEMA Foundation
Phase
Observational
Overall status
Completed
Start date
July 31, 2015
Completion date
February 15, 2018
Enrollment
3,910 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

aml